ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 122 filers reported holding ZS PHARMA INC in Q2 2015. The put-call ratio across all filers is 0.13 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $33,756,000 | +112.6% | 514,107 | +69.7% | 2.56% | +96.5% |
Q2 2015 | $15,874,000 | -7.0% | 302,988 | -25.3% | 1.30% | -15.1% |
Q1 2015 | $17,071,000 | -21.7% | 405,688 | -22.7% | 1.53% | -35.5% |
Q4 2014 | $21,812,000 | +17.3% | 524,702 | +10.7% | 2.38% | +10.6% |
Q3 2014 | $18,600,000 | – | 474,132 | – | 2.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 564,483 | $22,145,000 | 2.62% |
Redmile Group, LLC | 474,132 | $18,600,000 | 2.15% |
Novo Holdings A/S | 506,730 | $19,879,000 | 1.94% |
Ghost Tree Capital, LLC | 85,000 | $3,335,000 | 1.81% |
VHCP Management, LLC | 100,000 | $3,923,000 | 1.76% |
Atika Capital Management LLC | 31,000 | $1,216,000 | 0.94% |
PFM Health Sciences, LP | 729,044 | $28,600,000 | 0.66% |
WALL STREET ASSOCIATES | 143,400 | $5,626,000 | 0.58% |
Rock Springs Capital Management LP | 92,000 | $3,609,000 | 0.56% |
EMERALD MUTUAL FUND ADVISERS TRUST | 136,204 | $5,343,000 | 0.51% |